An essential role of ERK signalling in TPA-induced reactivation of Kaposi's sarcoma-associated herpesvirus

Journal of General Virology

Volumn 87, Issue 4, 2006, Pages 795-802

  Cohen, Adina ^a   Brodie, Chaya ^a   Sarid, Ronit ^a  

^a BAR ILAN UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

2 [1 (3 DIMETHYLAMINOPROPYL) 3 INDOLYL] 3 (3 INDOLYL)MALEIMIDE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN C FOS; PROTEIN KINASE C DELTA; ROTTLERIN; TRANSCRIPTION FACTOR AP 1;

ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; GENE EXPRESSION; GENE REPRESSION; HUMAN HERPESVIRUS 8; LATENT VIRUS INFECTION; NONHUMAN; PRIMARY EFFUSION LYMPHOMA; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; STIMULUS RESPONSE; VIRUS REACTIVATION; VIRUS REPLICATION; WESTERN BLOTTING;

CELL LINE; HERPESVIRUS 8, HUMAN; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; PROTEIN KINASE C-DELTA; PROTO-ONCOGENE PROTEINS C-FOS; PROTO-ONCOGENE PROTEINS C-JUN; SIGNAL TRANSDUCTION; TETRADECANOYLPHORBOL ACETATE; VIRUS ACTIVATION;

HUMAN HERPESVIRUS 8;

EID: 33645554691     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/vir.0.81619-0     Document Type: Article

References (65)

1. Akula, S. M., Ford, P. W., Whitman, A. G., Hamden, K. E., Shelton, J. G. & McCubrey, J. A. (2004). Raf promotes human herpesvirus-8 (HHV-8/KSHV) infection. Oncogene 23, 5227-5241.
2. Alessi, D. R., Cuenda, A., Cohen, P., Dudley, D. T. & Saltiel, A. R. (1995). PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J Biol Chem 270, 27489-27494.
3. Barber, S. A., Bruett, L., Douglass, B. R., Herbst, D. S., Zink, M. C. & Clements, J. E. (2002). Visna virus-induced activation of MAPK is required for virus replication and correlates with virus-induced neuropathology. J Virol 76, 817-828.
4. Bechtel, J. T., Liang, Y., Hvidding, J. & Ganem, D. (2003). Host range of Kaposi's sarcoma-associated herpesvirus in cultured cells. J Virol 77, 6474-6481.
5. Benn, J., Su, F., Doria, M. & Schneider, R. J. (1996). Hepatitis B virus HBx protein induces transcription factor AP-1 by activation of extracellular signal-regulated and c-Jun N-terminal mitogen-activated protein kinases. J Virol 70, 4978-4985.
6. Blackbourn, D. J., Fujimura, S., Kutzkey, T. & Levy, J. A. (2000). Induction of human herpesvirus-8 gene expression by recombinant interferon gamma. AIDS 14, 98-99.
7. Blass, M., Kronfeld, I., Kazimirsky, G., Blumberg, P. M. & Brodie, C. (2002). Tyrosine phosphorylation of protein kinase Cδ is essential for its apoptotic effect in response to etoposide. Mol Cell Biol 22, 182-195.
8. + cell line (BCP-1) from peripheral blood and characterizing its growth in Nod/SCID mice. Blood 91, 1671-1679.
9. Brown, H. J., Song, M. J., Deng, H., Wu, T.-T., Cheng, G. & Sun, R. (2003). NF-κB inhibits gammaherpesvirus lytic replication. J Virol 77, 8532-8540.
10. Bruder, J. T. & Kovesdi, I. (1997). Adenovirus infection stimulates the Raf/MAPK signaling pathway and induces interleukin-8 expression. J Virol 71, 398-404.
11. Cesarman, E., Moore, P. S., Rao, P. H., Inghirami, G., Knowles, D. M. & Chang, Y. (1995). In vitro establishment and characterization of two acquired immunodeficiency syndrome-related lymphoma cell lines (BC-1 and BC-2) containing Kaposi's sarcoma-associated herpesvirus-like (KSHV) DNA sequences. Blood 86, 2708-2714.
12. Chang, Y., Cesarman, E., Pessin, M. S., Lee, F., Culpepper, J., Knowles, D. M. & Moore, P. S. (1994). Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 266, 1865-1869.
13. Chang, J., Renne, R., Dittmar, D. & Ganem, D. (2000). Inflammatory cytokines and the reactivation of Kaposi's sarcoma-associated herpesvirus lytic replication. Virology 266, 17-25.
14. Chatterjee, M., Osborne, J., Bestetti, G, Chang, Y. & Moore, P. S. (2002). Viral IL-6-induced cell proliferation and immune evasion of interferon activity. Science 298, 1432-1435.
15. Chen, J. & Stinski, M. F. (2002). Role of regulatory elements and the MAPK/ERK or p38 MAPK pathways for activation of human cytomegalovirus gene expression. J Virol 76, 4873-4885.
16. Chen, J., Ueda, K., Sakakibara, S., Okuno, T., Parravicini, C., Corbellino, M. & Yamanishi, K. (2001). Activation of latent Kaposi's sarcoma-associated herpesvirus by demethylation of the promoter of the lytic transactivator. Proc Natl Acad Sci U S A 98, 4119-4124.
17. Cohen, A., Wolf, D. G., Guttman-Yassky, E. & Sarid, R. (2005). Kaposi's sarcoma-associated herpesvirus: clinical, diagnostic, and epidemiological aspects. Crit Rev Clin Lab Sci 42, 101-153.
18. Davis, D. A., Rinderknecht, A. S., Zoeteweij, J. P., Aoki, Y., Read-Connole, E. L., Tosato, G., Blauvelt, A. & Yarchoan, R. (2001). Hypoxia induces lytic replication of Kaposi sarcoma-associated herpesvirus. Blood 97, 3244-3250.
19. Deutsch, E., Cohen, A., Kazimirsky, G., Dovrat. S., Rubinfeld, H., Brodie, C. & Sarid, R. (2004). Role of protein kinase Cδ in reactivation of Kaposi's sarcoma-associated herpesvirus. J Virol 78, 10187-10192.
20. Dourmishev, L. A., Dourmishev, A. L., Palmeri, D., Schwartz, R. A. & Lukac, D. M. (2003). Molecular genetics of Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8) epidemiology and pathogenesis. Microbiol Mol Biol Rev 67, 175-212.
21. Dudley, D. T., Pang, L., Decker, S. J., Bridges, A. J. & Saltiel, A. R. (1995). A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proc Natl Acad Sci U S A 92, 7686-7689.
22. Favata, M. F., Horiuchi, K. Y., Manos, E. J. & 11 other authors (1998). Identification of a novel inhibitor of mitogen-activated protein kinase kinase. J Biol Chem 273, 18623-18632.
23. ERK signal transduction pathway during initial virus infection of quiescent primary B cells and disruption of Epstein-Barr virus latency by phorbol esters. J Virol 73, 8913-8916.
24. Grundhoff, A. & Ganem, D. (2004). Inefficient establishment of KSHV latency suggests an additional role for continued lytic replication in Kaposi sarcoma pathogenesis. J Clin Invest 113, 124-136.
25. Gschwendt, M., Muller, H. J., Kielbassa, K., Zang, R., Kittstein, W., Rincke, G. & Marks, F. (1994). Rottlerin, a novel protein kinase inhibitor. Biochem Biophys Res Commun 199, 93-98.
26. Gwack, Y., Hwang, S., Lim, C, Won, Y. S., Lee, C. H. & Choe, J. (2002). Kaposi's sarcoma-associated herpesvirus open reading frame 50 stimulates the transcriptional activity of STAT3. J Biol Chem 277, 6438-6442.
27. Haque, M., Davis, D. A., Wang, V., Widmer, I. & Yarchoan, R. (2003). Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) contains hypoxia response elements: relevance to lytic induction by hypoxia. J Virol 77, 6761-6768.
28. He, T.-C., Zhou, S., da Costa, L. T., Yu, J., Kinzler, K. W. & Vogelstein, B. (1998). A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci U S A 95, 2509-2514.
29. Jenner, R. G., Albà, M. M., Boshoff, C. & Kellam, P. (2001). Kaposi's sarcoma-associated herpesvirus latent and lytic gene expression as revealed by DNA arrays. J Virol 75, 891-902.
30. Kolch, W., Calder, M. & Gilbert, D. (2005). When kinases meet mathematics: the systems biology of MAPK signalling. FEBS Lett 579, 1891-1895.
31. Kong, X., San Juan, H., Behera, A., Peeples, M. E., Wu, J., Lockey, R. F. & Mohapatra, S. S. (2004). ERK-1/2 activity is required for efficient RSV infection. FEBS Lett 559, 33-38.
32. Krishnan, H. H., Naranatt, P. P., Smith, M. S., Zeng, L., Bloomer, C. & Chandran, B. (2004). Concurrent expression of latent and a limited number of lytic genes with immune modulation and anti-apoptotic function by Kaposi's sarcoma-associated herpesvirus early during infection of primary endothelial and fibroblast cells and subsequent decline of lytic gene expression. J Virol 78, 3601-3620.
33. Lan, K., Kuppers, D. A. & Robertson, E. S. (2005). Kaposi's sarcoma-associated herpesvirus reactivation is regulated by interaction of latency-associated nuclear antigen with recombination signal sequence-binding protein Jκ, the major downstream effector of the Notch signaling pathway. J Virol 79, 3468-3478.
34. Liang, Y. & Ganem, D. (2003). Lytic but not latent infection by Kaposi's sarcoma-associated herpesvirus requires host CSL protein, the mediator of Notch signaling. Proc Natl Acad Sci U S A 100, 8490-8495.
35. Liang, Y., Chang, J., Lynch, S. J., Lukac, D. M. & Ganem, D. (2002). The lytic switch protein of KSHV activates gene expression via functional interaction with RBP-Jκ (CSL), the target of the Notch signaling pathway. Genes Dev 16, 1977-1989.
36. Luo, H., Yanagawa, B., Zhang, J. & 7 other authors (2002). Coxsackievirus B3 replication is reduced by inhibition of the extracellular signal-regulated kinase (ERK) signaling pathway. J Virol 76, 3365-3373.
37. McCormick, C. & Ganem, D. (2005). The kaposin B protein of KSHV activates the p38/MK2 pathway and stabilizes cytokine mRNAs. Science 307, 739-741.
38. McLean, T. I. & Bachenheimer, S. L. (1999). Activation of cJUN N-terminal kinase by herpes simplex virus type 1 enhances viral replication. J Virol 73, 8415-8426.
39. Mercader, M., Taddeo, B., Panella, J. R., Chandran, B., Nickoloff, B. J. & Foreman, K. E. (2000). Induction of HHV-8 lytic cycle replication by inflammatory cytokines produced by HIV-1-infected T cells. Am J Pathol 156, 1961-1971.
40. Miller, G., Rigsby, M. O., Heston, L. & 7 other authors (1996). Antibodies to butyrate-inducible antigens of Kaposi's sarcoma-associated herpesvirus in patients with HIV-1 infection. N Engl J Med 334, 1292-1297.
41. Moore, P. S., Gao, S.-J., Dominguez, G. & 7 other authors (1996). Primary characterization of a herpesvirus agent associated with Kaposi's sarcoma. J Virol 70, 549-558.
42. Munshi, N., Ganju, R. K., Avraham, S., Mesri, E. A. & Groopman, J. E. (1999). Kaposi's sarcoma-associated herpesvirus-encoded G protein-coupled receptor activation of c-Jun amino-terminal kinase/stress-activated protein kinase and Lyn kinase is mediated by related adhesion focal tyrosine kinase/proline-rich tyrosine kinase 2. J Biol Chem 274, 31863-31867.
43. Naranatt, P. P., Akula, S. M., Zien, C. A., Krishnan, H. H. & Chandran, B. (2003). Kaposi's sarcoma-associated herpesvirus induces the phosphatidylinositol 3-kinase-PKC-ζ-MEK-ERK signaling pathway in target cells early during infection: implications for infectivity. J Virol 77, 1524-1539.
44. Naranatt, P. P., Krishnan, H. H., Svojanovsky, S. R., Bloomer, C., Mathur, S. & Chandran, B. (2004). Host gene induction and transcriptional reprogramming in Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8)-infected endothelial, fibroblast, and B cells: insights into modulation events early during infection. Cancer Res 64, 72-84.
45. Planz, O., Pleschka, S. & Ludwig, S. (2001). MEK-specific inhibitor U0126 blocks spread of Borna disease virus in cultured cells. J Virol 75, 4871-4877.
46. Renne, R., Zhong, W., Herndier, B., McGrath, M., Abbey, N., Kedes, D. & Ganem, D. (1996). Lytic growth of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in culture. Nat Med 2, 342-346.
47. Rodems, S. M. & Spector, D. H. (1998). Extracellular signal-regulated kinase activity is sustained early during human cytomegalovirus infection. J Virol 72, 9173-9180.
48. Rubinfeld, H. & Seger, R. (2004). The ERK cascade as a prototype of MAPK signaling pathways. Methods Mol Biol 250, 1-28.
49. Sakakibara, S., Ueda, K., Chen, J., Okuno, T. & Yamanishi, K. (2001). Octamer-binding sequence is a key element for the auto-regulation of Kaposi's sarcoma-associated herpesvirus ORF50/Lyta gene expression. J Virol 75, 6894-6900.
50. Sarid, R., Flore, O., Bohenzky, R. A., Chang, Y. & Moore, P. S. (1998). Transcription mapping of the Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) genome in a body cavity-based lymphoma cell line (BC-1). J Virol 72, 1005-1012.
51. Sodhi, A., Montaner, S., Patel, V., Zohar, M., Bais, C., Mesri, E. A. & Gutkind, J. S. (2000). The Kaposi's sarcoma-associated herpes virus G protein-coupled receptor up-regulates vascular endothelial growth factor expression and secretion through mitogen-activated protein kinase and p38 pathways acting on hypoxia-inducible factor 1α. Cancer Res 60, 4873-4880.
52. Song, J., Ohkura, T., Sugimoto, M., Mori, Y., Inagi, R., Yamanishi, K., Yoshizaki, K. & Nishimoto, N. (2002). Human interleukin-6 induces human herpesvirus-8 replication in a body cavity-based lymphoma cell line. J Med Virol 68, 404-411.
53. Sun, R., Lin S.-, F., Staskus, K., Gradoville, L., Grogan, E., Haase, A. & Miller, G. (1999). Kinetics of Kaposi's sarcoma-associated herpes-virus gene expression. J Virol 73, 2232-2242.
54. Suomalainen, M., Nakano, M. Y., Boucke, K., Keller, S. & Greber, U. F. (2001). Adenovirus-activated PKA and p38/MAPK pathways boost microtubule-mediated nuclear targeting of virus. EMBO J 20, 1310-1319.
55. Toullec, D., Pianetti, P., Coste, H. & 10 other authors (1991). The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C. J Biol Chem 266, 15771-15781.
56. Varthakavi, V., Browning, P. J. & Spearman, P. (1999). Human immunodeficiency virus replication in a primary effusion lymphoma cell line stimulates lytic-phase replication of Kaposi's sarcoma-associated herpesvirus. J Virol 73, 10329-10338.
57. Vieira, J., O'Hearn, P., Kimball, L., Chandran, B. & Corey, L. (2001). Activation of Kaposi's sarcoma-associated herpesvirus (human herpes-virus 8) lytic replication by human cytomegalovirus. J Virol 75, 1378-1386.
58. Wang, S., Liu, S., Wu, M.-H., Geng, Y. & Wood, C. (2001). Identification of a cellular protein that interacts and synergizes with the RTA (ORF50) protein of Kaposi's sarcoma-associated herpesvirus in transcriptional activation. J Virol 75, 11961-11973.
59. Wang, S. E., Wu, F. Y., Chen, H., Shamay, M., Zheng, Q. & Hayward, G. S. (2004). Early activation of the Kaposi's sarcoma-associated herpesvirus RTA, RAP, and MTA promoters by the tetradecanoyl phorbol acetate-induced AP1 pathway. J Virol 78, 4248-4267.
60. West, J. T. & Wood, C. (2003). The role of Kaposi's sarcoma-associated herpesvirus/human herpesvirus-8 regulator of transcription activation (RTA) in control of gene expression. Oncogene 22, 5150-5163.
61. Yang, X. & Gabuzda, D. (1999). Regulation of human immuno-deficiency virus type 1 infectivity by the ERK mitogen-activated protein kinase signaling pathway. J Virol 73, 3460-3466.
62. Ye, J., Shedd, D. & Miller, G. (2005). An Sp1 response element in the Kaposi's sarcoma-associated herpesvirus open reading frame 50 promoter mediates lytic cycle induction by butyrate. J Virol 79, 1397-1408.
63. Zachos, G., Clements, B. & Conner, J. (1999). Herpes simplex virus type 1 infection stimulates p38/c-Jun N-terminal mitogen-activated protein kinase pathways and activates transcription factor AP-1. J Biol Chem 274, 5097-5103.
64. Zhu, F. X., Cusano, T. & Yuan, Y. (1999). Identification of the immediate-early transcripts of Kaposi's sarcoma-associated herpes-virus. J Virol 73, 5556-5567.
65. Zoeteweij, J. P., Moses, A. V., Rinderknecht, A. S., Davis, D. A., Overwijk, W. W., Yarchoan, R., Orenstein, J. M. & Blauvelt, A (2001). Targeted inhibition of calcineurin signaling blocks calcium-dependent reactivation of Kaposi sarcoma-associated herpesvirus. Blood 97, 2374-2380.